Hanmi Pharm.'s latest marketcap:
As of 06/18/2025, Hanmi Pharm.'s market capitalization has reached $2.67 B. According to our data, Hanmi Pharm. is the 5042th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.67 B |
| Revenue (ttm) | 1.07 B |
| Net Income (ttm) | 78.75 M |
| Shares Out | 12.68 M |
| EPS (ttm) | 6.21 |
| Forward PE | 23.05 |
| Ex-Dividend Date | 06/27/2025 |
| Earnings Date | 07/29/2025 |
Hanmi Pharm.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/18/2025 | ₩2.67 B | 3.92% | 5042 |
| 12/30/2024 | ₩3.56 T | -20.49% | 5086 |
| 12/28/2023 | ₩4.47 T | 20.54% | 3850 |
| 12/29/2022 | ₩3.71 T | 10% | 4084 |
| 12/30/2021 | ₩3.37 T | -23.27% | 4921 |
| 12/30/2020 | ₩4.4 T | 25.97% | 3347 |
| 12/30/2019 | ₩3.49 T | -34.87% | 3497 |
| 12/28/2018 | ₩5.36 T | -19.03% | 2101 |
| 12/28/2017 | ₩6.62 T | 108.24% | 1984 |
| 12/29/2016 | ₩3.18 T | -58.07% | 3268 |
Company Profile
Hanmi Pharm. Co., Ltd.
Overview: Hanmi Pharm. Co., Ltd. is a biopharmaceutical company specializing in the manufacture and sale of pharmaceutical products. It operates in South Korea, China, Japan, the United States, and internationally.
Research Focus
The company targets high-unmet medical needs in key therapeutic areas, including:
- Obesity
- Metabolism
- Oncology
- Rare diseases
Key Products
Gugutams: A urological combination therapy featuring:
- Tamsulosin – For Obstructive Prostatic Growth (OPG)
- Tadalafil – For erectile dysfunction (ED)
Collaborations
The company has partnered with MEDIC Life Sciences Inc. to identify cancer biomarkers.
Company Background
Founded in 1973, Hanmi Pharm. is headquartered in Hwaseong-si, South Korea.
Frequently Asked Questions
-
What is Hanmi Pharm.'s (KRX-128940) current market cap?As of 06/18/2025, Hanmi Pharm. (including the parent company, if applicable) has an estimated market capitalization of $2.67 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Hanmi Pharm. (KRX-128940) rank globally by market cap?Hanmi Pharm. global market capitalization ranking is approximately 5042 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.